ADENOCARCINOMA OF THE ADRENAL GLAND IN A FEMALE DOG
DOI:
https://doi.org/10.35172/rvz.2022.v29.859Keywords:
Adrenocortical tumors, endocrine disease, hyperadrenocorticismAbstract
The aim of this article is to describe a case of adrenocortical neoplasm with manifestation of hyperadrenocorticism. Adrenocortical tumors originate from different types of cells and present varied clinical manifestations, which can be functional or non-functional. Adenocarcinomas are autonomous and functional in most cases, leading to excessive secretion of glucocorticoids, regardless of pituitary control. They corroborate the occurrence of hyperadrenocorticism (HAC) due to interference in the synthesis of cortisol. Clinical signs can be observed, as polyuria, compensatory polydipsia, polyphagia, blood pressure alterations, cardiac, renal and endocrine dysfunctions, among others. Diagnosis can be made in various ways, such as urinary cortisol measurements, adrenocorticotropic hormone stimulation, low-dose dexamethasone suppression tests, and imaging tests and histopathology. This article reports the case of a 13-year-old mixed-breed female dog with signs of polyuria and polydpsia. After discarding the initial diagnoses (diabetes mellitus and/or renal alterations), HAC was suspected, with further tests being performed. The test results showed an increase in the adrenal region, and adrenalectomy and hormone replacement with trilostane were recommended. The diagnosis of HAC was confirmed by histopathology as HAC secondary to adrenal gland adenocarcinoma. The patient also developed diabetes mellitus during postoperative treatment with prednisone, which made it necessary to discontinue the medication.
References
De Marco V. Hiperadrenocorticismo canino. In: Jericó MM, Neto JPA, Kogika MM, editors. Tratado de Medicina Interna de Cães e Gatos. 1st ed. Rio de Janeiro: Roca; 2015. p. 1691-1703.
Silva EO, Di Santis GW, Headley SA, Bracarense APFRL. Pathological Findings in the Adrenal Glands of 80 Dogs. Acta Sci Vet. 2018; 46:1604. Doi: https://doi.org/10.22456/1679-9216.88860. DOI: https://doi.org/10.22456/1679-9216.88860
Benedito GS, Rossi EM, Camargo MHB. Hyperadrenocorticism in Dogs - Literature Review. J Vet Sci Public Health. 2017;4(1):127-138. DOI: https://doi.org/10.4025/revcivet.v4i1.37156
Pöppl AG, Coelho IC, Silveira CA, Moresco MB, Carvalho GLC. Frequency of endocrinopathies and characteristics of affected dogs and cats in southern Brazil (2004-2014). Acta Sci Vet. 2016;44(1):1379. Doi: https://doi.org/10.22456/1679-9216.81099. DOI: https://doi.org/10.22456/1679-9216.81099
Martins FSM, Carvalho GLC, Jesus L, Pöppl AG, González FHD. 2019. Epidemiological, clinical and laboratory aspects in a case series of canine hyperadrenocorticism: 115 cases (2010-2014). Pesq Vet Bras. 2019;39(11):900-8. Doi: https://doi.org/10.1590/1678-5150-PVB-6105. DOI: https://doi.org/10.1590/1678-5150-pvb-6105
Borin-Crivellenti S, Malta CASA. A endocrinologia da poliúria e da polidipsia. Investigação. 2015:14(6):22-25. Doi: https://doi.org/10.26843/investigacao.v14i6.1073.
Sieber-Ruckstuhl N, Salesov E, Quante S, Riond B, Rentsch K et al. 2017. Effects of Trilostane on urinary Catecholamines and their metabolites in dogs with Hypercortisolism. BMC Vet Res. 2017;13(1):279. Doi: https://doi.org/10.1186%2Fs12917-017-1187-0. DOI: https://doi.org/10.1186/s12917-017-1187-0
Downloads
Published
How to Cite
Issue
Section
License
Este obra está licenciado com uma Licença Creative Commons Atribuição-NãoComercial 4.0 Internacional.